Monday May 5

Lunch will be served upon arrival at Engelsbergs Ironworks.

Session one: Precision prevention – medical and scientific aspects

• What is prevention and which different aspects of precision are relevant for preventive actions? 
• How are novel diagnostic tools and AI-driven risk prediction models shaping the future of precision prevention?   
• How can healthcare systems integrate precision prevention into routine care?  
• Does awareness of our health status and risk factors contribute to greater well-being, or can it have unintended consequences?    

Coffee Break

Session two: Economic aspects and precision prevention

• What are the advantages and challenges of different reimbursement models in healthcare? Which models best incentivize preventive care?  
• What lessons can we draw from real-world cases of outcome-based compensation in healthcare? 
• How can health bonds be leveraged to finance and promote preventive interventions in healthcare systems? 
• How can successful pilots be scaled?  

Dinner and fireside chats

Tuesday May 6

Breakfast

Session three: How can society and healthcare systems transition toward more effective preventive approaches?

• How can the impact of preventive interventions be effectively measured? 
• What is required for healthcare systems to transition to a more preventive approach? 
• Which stakeholders in society are key to driving the transition toward prevention? 
• What role do individuals play in maintaining and improving their own health? 

Coffee Break

Session four: Precision prevention in the future – business, societal and ethical perspectives.

• What new business opportunities are emerging in the field of precision prevention? 
• Is there an increasing demand for precise preventive services in the market? Who will lead the development of this market? 
• What factors in our environment are most important for our health and well-being? How can we build healthier societies based on current knowledge? 
• What are the key drivers and challenges in the transition to precision prevention? 

Luncheon

Bus transportation to central Stockholm

About the 14 confirmed speakers

Afzelius, Lovisa, General Partner at Flagship Pioneering. She has co-founded seven companies operating at the intersection of biology and AI, including Alltrna, Apriori Bio, Metaphore Biotechnologies, and Prologue Medicines. Lovisa has served as CEO, co-founder, president, board chairman, and executive director in emerging biotech and large pharma companies. Prior to Flagship, Lovisa held leadership roles at Pfizer and Astra Zeneca for 15+ years, developing drugs, including several on the market in the autoimmunity space. Lovisa has a PhD in computational chemistry from Uppsala University, an MS in integrative pharmacology from Gothenburg University, and an MBA from the MIT Sloan School of Management. 

Arrhenius, Gustaf, Director of the Institute for Futures Studies (IFFS) since 2015 and a Professor of Practical Philosophy. He holds a Ph.D. in Philosophy from University of Toronto and a doctorate in Practical Philosophy from Uppsala University. His research focuses on moral and political philosophy, particularly on what we owe to future generations, democratic theory, and fair distribution of power. He has been a visiting researcher at many institutions, such as the University of Oxford and CNRS. He is a member of Academia Europaea and serves on the board of Sweden’s Health and Social Care Analysis Agency and UUniCORN at Uppsala University.

Dahlen, Micael, holds the Chaired Professor in Wellbeing, Welfare and Happiness and is the Center for Wellbeing, Welfare and Happiness (CWWH) director at Stockholm School of Economics. Micael has a particular interest in what constitutes a good life and how truly good economics, in which the actions of and exchanges between individuals, organizations, and society have extended and synergetic effects, can make a good life for all.

Jonsdottir, Ingibjörg, Professor at the School of Public Health and Community Medicine at the Sahlgrenska Academy, Gothenburg University and a director for the Institute of Stress Medicine (ISM). ISM is a research institute located in the western part of Sweden that works with different aspects of work-related stress, including clinical research and research on organizational and social work environments. Ingibjörg is involved in projects related to clinical research focusing on individuals with burnout/exhaustion, as well as research focusing on organizational and social work environments.

Larsson, Stefan, Advisor in Healthcare and Life Sciences at International Consortium for Health Outcomes Measurement (ICHOM). Stefan Larsson, MD, PhD., trained at Karolinska Institutet, Harvard Medical School and MRC Human Genomics unit in UK, an Associate Professor at KI. He worked at The Boston Consulting Group 1996 -2021. He was the founder and first leader of BCG’s Global Payer and Provider sector and its Health Systems sector. He led BCG’s work on Value based health care. Stefan is a co-founder and the board chair of ICHOM, International Consortium of Health Outcomes Measurement, an independent not-for-profit organization. He is a Distinguished Fellow with the World Economic Forum. He published the book “The Patient Priority” and has >30 peer reviewed papers.

Lindgren, Peter, Managing director of The Swedish Institute for Health Economics and is a professor of health economics at Karolinska Institutet. Peter has over 20 years of experience in Swedish and international health economic studies across various fields, with nearly 100 scientific publications, and has held leading roles in consulting and R&D activities. Since finishing his PhD on the economics of cardiovascular prevention, the area of prevention has always been close to his heart.

Nihlén Fahlqvist, Jessica, Associate Professor in Practical Philosophy and a Senior Lecturer in Biomedical Ethics at the Centre for Research Ethics and Bioethics. She holds a PhD in Philosophy from the Royal Institute of Technology and has conducted postdoctoral research at Delft University of Technology. Her work focuses on moral responsibility, public health, and technology. She also teaches ethics in medical and biotechnology programs and leads master's courses in public health ethics.

Olausson Mats, SEB, Senior Advisor, Climate & Sustainable Finance, Sustainable Banking, SEB. His primary responsibilities include tailored advisory on green and social bonds, sustainability linked loans and bonds as well as other sustainable finance opportunities such as Health Impact Bonds to issuers, investors and other stakeholders. Mats has provided structural advice to over 80 clients in developing frameworks for sustainable finance solutions within various sectors and regions. Prior to joining SEB, he worked for UNDP in Bolivia and at SIDA. Mats has a Bachelor of Social Science with a major in Economics (coupled with Development Studies and Spanish) from the Stockholm University.

Orring, Emilie, Group leader for Moderaterna (Moderate Party) since January 2020 and second vice chairman of the Regional Board in Uppsala. She served as Chair of the Regional Executive Board in Region Uppsala from January 2020 to February 2024, becoming the first woman in this position. After a new administration was formed without the Moderates, she became the second vice chair of the Regional Executive Board and an opposition councillor. She studied at Uppsala and Lund University, earning a Bachelor of Political Science and a Bachelor of Economics in Commercial Law. She has previously worked as a political secretary in Uppsala Municipality and at the Swedish Migration Agency.

Petrovski, Slavé, Human geneticist by training with over 15 years’ experience leading large-scale omics studies. In this time, Slavé has contributed to shaping the field of contemporary population and statistical genomics, including introducing machine learning & advanced analytics to identify numerous drug targets across a diverse range of diseases. Since 2017, as the Vice President and Head of AstraZeneca’s Centre for Genomics Research (CGR) Slavé is accountable for architecting and delivering the company’s Genomics Initiative strategy. He has built in-house capabilities and expertise across key domains: Bioinformatics, Statistical Genetics, Innovative AI/ML methods, multi-omics, and clinical sciences. Applying these cross-disciplinary skills to large-scale omics datasets.

Stanworth, Neil, Founding Director of ATQ Consultants, specializing in outcome-based commissioning including social outcomes contracts (SOCs) and social impact bonds (SIBs). He has worked extensively with commissioners and providers to develop SOCs, SIBs and other innovative contracts. He is also an experienced researcher and evaluator of SOCs and SIBs for the UK government and is leading the evaluation of the Commissioning Better Outcomes Fund (CBO) in partnership with Ecorys UK. Neil is a former fellow of practice at the Government Outcomes Lab (GO Lab), part of Oxford University, and contributes regularly to GO Lab guidance and events.

Stenfors, Cecilia, Associate Professor, researcher, and university lecturer at the Department of Psychology, Stockholm University, where she leads the Stenfors Lab. Her research focuses on the interplay between human, environmental, and planetary health and sustainability. Studies explore the interconnection between our environments and human health, cognition and well-being. She leads projects examining how different natural and urban environment exposures, as well as work-life factors, affect health and wellbeing — both before and during the Covid-19 pandemic.

Sundberg, Carl Johan, Professor at the Department of Physiology and Pharmacology at Karolinska Institutet and Dean for Karolinska Institutet Campus North. His research focuses on the effects and role of physical activity in the prevention and treatment of disease. He is elected to the Royal Swedish Academy of Engineering Sciences and has been a member or chairman of numerous academic and industry boards.

Trolle Lagerros, Ylva, Holds the Prince Daniel Professorship in Cardiovascular Prevention at Karolinska Institutet. She is a specialist in internal medicine with a focus on obesity. Her research spans from how lifestyle habits influence the risk of cardiovascular disease to clinical studies and intervention studies aimed at implementing and maintaining healthy lifestyle habits in at-risk groups.

Stockholm Science City Foundation is arranging the symposium in collaboration with Nordstjernan.

Back to the start page for The Future of Life Science >>